Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

By P. Ridker, N. Rifai, Nancy R. Cook, G. Bradwin, J. Buring. Journal of the American Medical Association (JAMA), 2005

821 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/6d63798348bf15552bb54d4096f963481ea71c83

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. P. Ridker
2. N. Rifai
3. Nancy R. Cook
4. J. Buring
5. Peter Libby
6. Jay P. Singh
7. L. Melvin

In Endocrinology, Diabetes and Metabolism

1. P. Ridker
2. N. Rifai
3. Peter Libby
4. Børge G. Nordestgaard
5. Giuseppe Jurman
6. Davide Chicco

In Surgery

1. P. Ridker
2. N. Rifai
3. Nancy R. Cook
4. J. Buring
5. Peter Libby
6. L. Melvin
7. G. Hansson

Citations in the corpus

• A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk (2011, background): “3 studies Nurses Hea t 11 , Copen agen City Heart (14), Women’s Health* (15)] included in both analyses D.”
• Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. (2007, background): “80).(20) Thus, model B substituted total cholesterol and HDL-C.”
• C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. (2007, positive): “Both of these contemporary European cohorts found the impact of hsCRP to be at least as large as that of most usual risk factors, data fully consistent with other reports (55).”